Vitamin D-Binding Protein Clearance Ratio Is Significantly Associated with Glycemic Status and Diabetes Complications in a Predominantly Vitamin D-Deficient Population

Introduction Studies have shown increased urine excretion of vitamin D-binding protein (VDBP) in patients with diabetic nephropathy (DN) resulting from postulated mechanisms linked to renal tubular damage. In this study, we evaluate the utility of VDBP clearance ratio as a novel determinant of glycemic status, DN, and other diabetes-associated complications. Methods Levels of vitamin D, HbA1c, serum, urine concentrations of VDBP, and creatinine were measured in 309 subjects. The ratio of urine microalbumin to creatinine was determined to categorize subjects as normoalbuminuric (NAO), microalbuminuric (MIA), and macroalbuminuric (MAA). The VDBP clearance ratio was calculated. Results Mean VDBP clearance ratios in NAO, MIA, and MAA were 0.7, 4, and 15, respectively. Significant positive correlations of VDBP clearance ratio were found with age, WC, SBP, DBP, TG, glucose, HbA1c, urine VDBP, urine microalbumin, and urine microalbumin/creatinine, and a significant negative correlation was found with the steady-state estimate of beta cell function (B%). Receiver operating curve (ROC) analyses of the use of VDBP clearance ratio for detection of albumin status shows a value of 0.81 for the area under the curve. Conclusions The strong associations of VDBP clearance ratio with glycemic control and diabetes-associated complications suggest that this index could play a wider role in detection and/or pathogenesis and complications of diabetes.

[1]  N. Abdella,et al.  Cross-sectional study of the determinants and associations of sex hormone-binding globulin concentrations in first degree relatives (FDR) of patients with Type 2 Diabetes Mellitus. , 2017, Diabetes research and clinical practice.

[2]  T. Dschietzig,et al.  Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography , 2016, PloS one.

[3]  K. Okasha,et al.  Urinary level of vitamin D-binding protein as a new biomarker for diabetic nephropathy , 2016 .

[4]  Yuan Wang,et al.  Changes in serum and urine vitamin D binding protein concentrations in type 2 diabetes , 2015 .

[5]  R. El-Sokkary,et al.  Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus , 2015, Molecular and Cellular Biochemistry.

[6]  V. Tesar,et al.  Vitamin D Binding Protein Is Not Involved in Vitamin D Deficiency in Patients with Chronic Kidney Disease , 2015, BioMed research international.

[7]  Yuqian Li,et al.  Association of the vitamin D binding protein polymorphisms with the risk of type 2 diabetes mellitus: a meta-analysis , 2014, BMJ Open.

[8]  S. Bajaj,et al.  Vitamin D levels and microvascular complications in type 2 diabetes , 2014, Indian journal of endocrinology and metabolism.

[9]  J. Ge,et al.  Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy , 2013, Experimental and therapeutic medicine.

[10]  G. Navis,et al.  Urinary Vitamin D Binding Protein: A Potential Novel Marker of Renal Interstitial Inflammation and Fibrosis , 2013, PloS one.

[11]  Wan-long Tan,et al.  Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE). , 2012, Journal of proteomics.

[12]  R. Thadhani,et al.  Vitamin D therapy in chronic kidney disease and end stage renal disease. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[13]  Sihyun Cho,et al.  Urinary vitamin D-binding protein is elevated in patients with endometriosis. , 2012, Human reproduction.

[14]  R. Gans,et al.  Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease , 2012, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  N. Abdella,et al.  Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes? , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[16]  G. Cockrell,et al.  Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? , 2011, The Journal of clinical endocrinology and metabolism.

[17]  Andrea M. Wessell,et al.  The Association of Vitamin D Deficiency and Insufficiency with Diabetic Nephropathy: Implications for Health Disparities , 2009, The Journal of the American Board of Family Medicine.

[18]  G. Cockrell,et al.  Microalbuminuria in Type 1 Diabetes Is Associated With Enhanced Excretion of the Endocytic Multiligand Receptors Megalin and Cubilin , 2009, Diabetes Care.

[19]  N. Wareham,et al.  Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance , 2008, Diabetes.

[20]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[21]  J. Manson,et al.  Vitamin D and calcium intake in relation to type 2 diabetes in women. , 2006, Diabetes care.

[22]  E. Ford,et al.  Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. , 2005, Diabetes care.

[23]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[24]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[25]  W. Herman,et al.  Does microalbuminuria predict diabetic nephropathy? , 2001, Diabetes care.

[26]  S. Adami,et al.  High prevalence of hypovitaminosis D in female type 2 diabetic population. , 2001, Diabetes care.

[27]  P. White,et al.  The Multifunctional Properties and Characteristics of Vitamin D-binding Protein , 2000, Trends in Endocrinology & Metabolism.

[28]  Henrik Vorum,et al.  An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3 , 1999, Cell.

[29]  R. Kahn Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomic nervous system testing. , 1992, Diabetes care.

[30]  J. Haddad,et al.  Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. , 1986, The Journal of clinical endocrinology and metabolism.

[31]  D. Ewing,et al.  Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. , 1980, Annals of internal medicine.

[32]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[33]  H. Taskapan,et al.  25(OH) Vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance , 2006, International Urology and Nephrology.

[34]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .